Skip to main content

Table 1 Baseline characteristics of the study cohort

From: Prognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertension

 

Whole cohort (n = 150)

Mean ± SD or n and (%)

n

Characteristics

  

Age, years

63.3 ± 14.5

150

Height, cm

166.3 ± 8.7

149

Weight, kg

78.0 ± 16.8

150

Body mass index

28.2 ± 5.7

149

Sex, female

93 (62)

149

6-min walking distance

331 ± 126

118

WHO functional class

 

130

 II

25 (19.2)

 

 III

90 (69.2)

 

 IV

15 (11.6)

 

PAH classification

  

Idiopathic PAH

44 (29.3)

150

heritable PAH

4 (2.7)

 

Associated PAH

50 (33.4)

 

Other PAH*

52 (34.7)

 

PAH therapy

  

Monotherapy

98 (65.3%)

150

Double combination

50 (33.3%)

 

Triple combination

2 (1.4%)

 

PAH medication

  

Calcium channel blocker

12 (8.0%)

150**

Endothelin receptor antagonist

62 (41.3%)

 

Phosphodiesterase 5 inhibitor

116 (77.3%)

 

Prostacyclin

2 (1.3%)

 

Soluble guanylate cyclase stimulator

7 (4.8%)

 

Laboratory

  

Creatinine, mg/dl

1.05 ± 0.42

149

Glomerular filtration rate, %

69.2 ± 25.2

143

Iron, µg/dl

13.9 ± 6.7

74

Hemoglobin, g/dl

14.5 ± 1.8

149

Iron deficiency

40 (54.1)

74

Hemoglobin deficiency

16 (10.7)

149

Ferritin < 40, ng/ml

13 (16.0)

81

MCV < 83, fl

21 (14.1)

149

MCH < 27, pg/cell

17 (11.4)

149

MCHC < 30, g/dl

6 (4.0)

149

Hypochromic erythrocytes > 2%

21 (33.9)

62

Diffusion capacity

  

DLCO SB, %

48.7 ± 22.3

130

Echocardiography

  

Right atrial area, cm2

20.5 ± 6.3

142

Right ventricular area, cm2

24.4 ± 7.1

145

Systolic pulmonary arterial pressure, mmHg

63.6 ± 19.5

147

Tricuspid annular plane systolic excursion

1.9 ± 0.6

146

Right heart catheter

  

Right atrial pressure, mmHg

8.0 ± 4.7

111

Mean pulmonary arterial pressure, mmHg

43.7 ± 12.4

150

Cardiac output, l/min

4.6 ± 1.3

134

Pulmonary arterial wedge pressure, mmHg

9.7 ± 3.1

143

Pulmonary vascular resistance, dynes*sec*cm−1

651 ± 323

142

  1. SD  standard deviation, PAH  pulmonary arterial hypertension, MCV  mean corpuscular volume, MCH  mean corpuscular hemoglobin, MCHC  mean corpuscular hemoglobin concentration, DLCO diffusion capacity of carbon monoxide; *Other PAH  atypical PAH including 33 patients with cardiac and 19 with pulmonary comorbidities; **patients can belong to more than one category